Is Sanofi Now an Opportunity After Recent Share Price Weakness? [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Despite a solid 5 year gain of 27.7%, the stock is down 1.8% over the last week, 6.3% over the last month, and 13.0% year to date, signaling a notable reset in expectations. Recently, investors have been weighing Sanofi's shifting strategic priorities and its evolving drug pipeline, which has reshaped sentiment around its long term growth profile. At the same time, renewed focus on innovation in immunology and rare diseases has sparked debate over whether the market is underestimating its future cash flows. On our valuation framework, Sanofi scores a perfect 6 out of 6 for being undervalued across key checks. This makes it a prime candidate to test against multiple valuation approaches, and we will close by looking at an even better way to interpret what those valuation signals really mean. Find out why Sanofi's -6.3% return over the last year is lagging behind its peers. A Discounted Cash Flow model estimates what a company is worth by projecting the cash it can generate in
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Weekly Recap: 13 Health Press Releases You Need to See [Yahoo! Finance]Yahoo! Finance
- Global Pulmonary Embolism Market Set for Growth with Increasing DVT and PE Cases [Yahoo! Finance]Yahoo! Finance
- Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades [Yahoo! Finance]Yahoo! Finance
- GSK obtains FDA approval for Exdensur in severe asthma [Yahoo! Finance]Yahoo! Finance
- Press release: Availability of the Q4 2025 Aide memoireGlobeNewswire
SNY
Sec Filings
- 12/15/25 - Form 6-K
- 12/12/25 - Form 6-K
- 12/3/25 - Form 6-K
- SNY's page on the SEC website